Health Canada
Symbol of the Government of Canada
About Health Canada

Karntien, Karntien Easy to Slim, Armstrong Natural Herbal Supplement, Enhanix New Extra Men's Formula, Power 58 Extra and Platinum Power 58 Extra

Foreign Product Alert
2008-136
August 18, 2008
For immediate release

Health Canada is advising consumers not to use the products specified below due to concerns about possible side-effects. More info

Date of alert: August 18, 2008
Source of Alert: Hong Kong Department of Health
Product Names: Karntien, Karntien Easy to Slim, Armstrong Natural Herbal Supplement, Enhanix New Extra Men's Formula, Power 58 Extra and Platinum Power 58 Extra
Manufacturer / Place of Origin: Unknown / China

Product Description
Karntien and Karntien Easy to Slim are promoted for weight loss. The other four products - Armstrong Natural Herbal Supplement, Enhanix New Extra Men's Formula, Power 58 Extra, and Platinum Power 58 Extra - are marketed for sexual enhancement and the treatment of erectile dysfunction.

Karntien:

Karntien

Karntien Easy to Slim:

Karntien Easy to Slim

Armstrong Natural Herbal Supplement:

Armstrong Natural Herbal Supplement

Enhanix New Extra Men's Formula:

Enhanix New Extra Men's Formula

Power 58 Extra:

Power 58 Extra

Platinum Power 58 Extra:

Platinum Power 58 Extra

Reason for Warning
The Hong Kong Department of Health warned consumers not to buy or use the six products listed above because they were found to contain undeclared pharmaceutical ingredients.

Karntien and Karntien Easy to Slim were adulterated with sibutramine and a compound that is similar in structure to sibutramine (N-desmethylsibutramine). Sibutramine is a prescription drug used in the treatment of obesity and should only be used under the supervision of a health care professional.

Armstrong Natural Herbal Supplement, Enhanix New Extra Men's Formula, Power 58 Extra, and Platinum Power 58 Extra were adulterated with tadalafil or unapproved substances with structures similar to tadalafil and vardenafil.

Tadalafil and vardenafil are prescription drugs used for the treatment of erectile dysfunction, and should only be used under the supervision of a health care professional.

Possible Side-Effects
Unsupervised use of sibutramine may cause headaches, increased heart rate and blood pressure, chest pain and stroke.

Unsupervised use of tadalafil and vardenafil by patients with heart disease can result in serious cardiovascular side-effects such as sudden cardiac death, heart attack, stroke, hypertension, chest pain and abnormal heartbeat.

Use of tadalafil and vardenafil may also beassociated with other side-effects including temporary vision loss, seizure, prolonged erection, headache, flushing, nasal congestion and abdominal pain. Tadalafil and vardenafil should not be used by individuals taking any type of nitrate drug (e.g., nitroglycerine) due to the risk of developing potentially life-threatening low blood pressure.

-30-

Media Inquiries:
Health Canada
(613) 957-2983

For more details on these Foreign Product Alerts, please visit the Health Canada Web site.


These products are not authorized for sale in Canada and have not been found in the Canadian marketplace, but it is possible they may have been brought into the country by travellers or purchased over the Internet.

Canadians who have this product are advised not to use it, and should consult with a health care professional if they have concerns about their health related to the use of this product.

Drugs and natural health products that are authorized for sale in Canada will have either an eight-digit Drug Identification Number (DIN), a Natural Product Number (NPN) or a Homeopathic Medicine Number (DIN-HM) on the label. These numbers indicate that the products have been assessed by Health Canada for safety, effectiveness and quality.

Health Canada advises Canadians to contact the Health Products and Food Branch Inspectorate at 1-800-267-9675 if they find any of the products listed above in the Canadian marketplace.

For more information about the information contained in this advisory, please contact Health Canada's public inquiries line at (613) 957-2991 or toll-free at 1-866-225-0709.

As of the date of this posting, no adverse reactions suspected to be associated with the use of this product have been reported in Canada.